ArticleEcancermedicalscience2025
A rare case of clear cell Hidradenocarcinoma presenting with recurrent pleural and cardiac effusion.
Article in Ecancermedicalscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clear cell hidradenocarcinoma (HAC) is a rare and aggressive malignant tumour originating from eccrine sweat glands, accounting for only 0.001% of all tumours. HAC primarily occurs in the head and neck region, with a high propensity for local recurrence and distant metastases. This case report details the unusual presentation of a 66-year-old male with a history of myocardial infarction, hypertension and a significant smoking history, who presented with abdominal pain and progressive shortness of breath. Diagnostic imaging revealed pleural and pericardial effusion and initial workup, including biopsies from pleura, skin and lymph nodes, was inconclusive. Subsequent histopathological examination suggested a diagnosis of HAC with metastases to the pleura, pericardium, lymph nodes, bones and subcutaneous tissues. Despite aggressive diagnostic efforts, the patient succumbed to the disease before chemotherapy could be initiated. This case underscores the diagnostic challenges of HAC, particularly with its atypical presentation and rare metastatic sites, such as the pleura and pericardium. The report emphasises the need for awareness of this rare malignancy and its potential for rapid, fatal progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.